MedPath

Accord Healthcare Ltd.

🇮🇳India
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:0

Trial Phases

1 Phases

Phase 3:2

Drug Approvals

1

EMA:1

Drug Approvals

Dimethyl fumarate Accord

Authorization Status
Authorised
Approval Date
Apr 22, 2024
EMA

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
2 (100.0%)
No trials found

News

Henlius' Serplulimab Makes History as First PD-1 Inhibitor Approved in EU for Small Cell Lung Cancer

Shanghai Henlius Biotech's serplulimab (Hetronifly) receives European Commission approval as the first anti-PD-1 antibody for extensive-stage small cell lung cancer treatment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.